Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Colonic Neoplasms 4Neoplasm Metastasis 3Colorectal Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Melanoma 2Locally Advanced Rectal Cancer (LARC) 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma 1Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1Osteosarcoma 1Neoplasms by Site 1MMR-D/MSI-H Colorectal Cancers 1Lung Neoplasms 1Hodgkin Disease 1Hepatoblastoma 1Head and Neck Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Fallopian Tube Neoplasms 1Ependymoma 1Endometrial Neoplasms 1

Interventions

dostarlimab 2Radiotherapy 2Oxaliplatin 2sintilimab 1irinotecan sucrosofate 1XELOX 1Neoadjuvant Therapy 1Immune Checkpoint Inhibitors 1Endoscopic Mucosal Resection 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer (LARC) × dostarlimab × Gastrointestinal × Clear all
NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
270 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT07269249 2025-12-08

RW-NEDOS

National Cancer Institute, Naples

Recruiting
50 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡